Ischemic Heart Disease, also referred to as coronary artery disease (CAD), is a prevalent and serious cardiovascular condition that stems from a compromised blood supply to the heart muscle. This medical condition arises when the coronary arteries, responsible for delivering oxygen-rich blood to the heart, undergo a narrowing or blockage due to the accumulation of fatty deposits known as plaques. This process, called atherosclerosis, significantly hampers the normal blood flow, leading to a shortage of oxygen supply to the heart. The consequences of Ischemic Heart Disease manifest in various ways, with individuals often experiencing chest pain or discomfort, a condition known as angina. In more severe cases, this insufficient blood flow can result in a heart attack, causing damage to the heart muscle and potentially leading to life-threatening complications. Given its widespread prevalence, Ischemic Heart Disease stands as a major contributor to both morbidity and mortality on a global scale.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States